{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:49:49Z","timestamp":1760143789213,"version":"build-2065373602"},"reference-count":48,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T00:00:00Z","timestamp":1607040000000},"content-version":"am","delay-in-days":399,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.lpm.2019.05.029","type":"journal-article","created":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T17:55:47Z","timestamp":1562867747000},"page":"1222-1228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"P1","title":["Dysfonction \u00e9rectile et traitement antihypertenseur\u00a0: impact des diff\u00e9rentes classes th\u00e9rapeutiques et conduite \u00e0 tenir \u00e0 l\u2019\u00e9gard du traitement"],"prefix":"10.1016","volume":"48","author":[{"given":"B\u00e9atrice","family":"Bouhanick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Blacher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Huyghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie H\u00e9l\u00e8ne","family":"Colson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Marc","family":"Boivin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Mounier-Vehier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Denolle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Pierre","family":"Fauvel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2019.05.029_bib0250","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1524-6175.2006.04708.x","article-title":"Sexual dysfunction in essential hypertension: myth or reality\u00a0?","volume":"8","author":"Doumas","year":"2006","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.lpm.2019.05.029_bib0255","doi-asserted-by":"crossref","first-page":"469","DOI":"10.2164\/jandrol.04191","article-title":"Factors affecting the increased prevalence of erectile dysfunction in Greek hypertensive compared with normotensive subjects","volume":"27","author":"Doumas","year":"2006","journal-title":"J Androl"},{"key":"10.1016\/j.lpm.2019.05.029_bib0260","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1524-6175.2002.00862.x","article-title":"Sexual dysfunction in patients with hypertension: implications for therapy","volume":"4","author":"Ferrario","year":"2002","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.lpm.2019.05.029_bib0265","first-page":"1","article-title":"Sexual dysfunction related to drugs: a critical review. Part IV: cardiovascular drugs","volume":"48","author":"La Torre","year":"2015","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.lpm.2019.05.029_bib0270","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1464-410X.2008.07536.x","article-title":"Effect of aldosterone on isolated human penile corpus cavernosum tissue","volume":"102","author":"Muguruma","year":"2008","journal-title":"BJU Int"},{"key":"10.1016\/j.lpm.2019.05.029_bib0275","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1365-2265.1978.tb03578.x","article-title":"Endocrine effects of spironolactone in man","volume":"9","author":"Tidd","year":"1978","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.lpm.2019.05.029_bib0280","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/jama.1973.03220280028007","article-title":"Adverse reactions to spironolactone. A report from the Boston Collaborative Drug Surveillance Program","volume":"225","author":"Greenblatt","year":"1973","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2019.05.029_bib0285","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/0002-9149(87)91030-7","article-title":"Efficacy and tolerance of spironolactone in essential hypertension","volume":"60","author":"Jeunemaitre","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.lpm.2019.05.029_bib0290","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1001\/jama.1985.03350460063022","article-title":"Long-term surveillance for adverse effects of antihypertensive drugs","volume":"253","author":"Curb","year":"1985","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2019.05.029_bib0295","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1056\/NEJM199304013281303","article-title":"Single-drug therapy for hypertension in men. A comparison of six antihypertensive agents with placebo. The Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents","volume":"328","author":"Materson","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2019.05.029_bib0300","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/archinte.1988.00380040028006","article-title":"Sexual symptoms in hypertensive patients. A clinical trial of antihypertensive medications","volume":"148","author":"Croog","year":"1988","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.lpm.2019.05.029_bib0305","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.HYP.29.1.8","article-title":"Long-term effects on sexual function of five antihypertensive drugs and nutritional hygienic treatment in hypertensive men and women. Treatment of Mild Hypertension Study (TOMHS)","volume":"29","author":"Grimm","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.lpm.2019.05.029_bib0310","doi-asserted-by":"crossref","first-page":"613","DOI":"10.7326\/0003-4819-114-8-613","article-title":"Effect of antihypertensives on sexual function and quality of life: the TAIM Study","volume":"114","author":"Wassertheil-Smoller","year":"1991","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.lpm.2019.05.029_bib0315","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/archinte.1991.00400120048008","article-title":"The impact of diuretic therapy on reported sexual function","volume":"151","author":"Chang","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.lpm.2019.05.029_bib0320","first-page":"236","article-title":"Antihypertensive therapy and male sexual dysfunction","volume":"234","author":"Hogan","year":"1980","journal-title":"Psychosomatics"},{"key":"10.1016\/j.lpm.2019.05.029_bib0325","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1291\/hypres.23.33","volume":"23","author":"Ogihara","year":"2000","journal-title":"Hypertens Res"},{"key":"10.1016\/j.lpm.2019.05.029_bib0330","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S0022-5347(05)67138-8","article-title":"Hypertension is associated with severe erectile dysfunction","volume":"164","author":"Burchardt","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.lpm.2019.05.029_bib0335","first-page":"539","article-title":"Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Report of Medical Research Council Working Party on Mild to Moderate Hypertension","volume":"2","author":"[No authors listed]","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2019.05.029_bib0340","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/jama.288.3.351","article-title":"Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction","volume":"288","author":"Ko","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2019.05.029_bib0345","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/bmj.291.6488.97","article-title":"MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party","volume":"291","author":"[No authors listed]","year":"1985","journal-title":"Br Med J"},{"key":"10.1016\/j.lpm.2019.05.029_bib0350","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/S0895-7061(98)00139-3","article-title":"Sexual function in hypertensive males treated with lisinopril or atenolol: a cross-over study","volume":"11","author":"Fogari","year":"1998","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.lpm.2019.05.029_bib0355","first-page":"22","article-title":"Self reported sexual dysfunction in men and women treated with bisoprolol, hydrochlorothiazide, enalapril, amlodipine. Placebo, or bisoprolol\/hydrochlorothiazide","volume":"1","author":"Prisant","year":"1999","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.lpm.2019.05.029_bib0360","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/sj.ijir.3900787","article-title":"Effects of beta-blockers on sexual performance in men with coronary heart disease. A prospective, randomized and double blinded study","volume":"13","author":"Franzen","year":"2001","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.lpm.2019.05.029_bib0365","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1440-1681.2007.04551.x","article-title":"Nitric oxide, erectile dysfunction and beta-blocker treatment (MR NOED study): benefit of nebivolol versus metoprolol in hypertensive men","volume":"34","author":"Brixius","year":"2007","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.lpm.2019.05.029_bib0370","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1755-5922.2009.00123.x","article-title":"Erectile dysfunction in high-risk hypertensive patients treated with beta-blockade agents","volume":"28","author":"Cordero","year":"2010","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/j.lpm.2019.05.029_bib0375","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2165\/00044011-200525060-00006","article-title":"A Randomised comparison of the effects of nebivolol and atenolol with and without chlorthalidone on the sexual function of hypertensive men","volume":"25","author":"Boydak","year":"2005","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.lpm.2019.05.029_bib0380","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1745-7262.2006.00076.x","article-title":"Beneficial effects of switching from beta-blockers to nebivolol on the erectile function of hypertensive patients","volume":"8","author":"Doumas","year":"2006","journal-title":"Asian J Androl"},{"key":"10.1016\/j.lpm.2019.05.029_bib0385","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.ehj.2003.08.016","article-title":"Report of erectile dysfunction after therapy with beta-blockers is related to patient knowledge of side effects and is reversed by placebo","volume":"24","author":"Silvestri","year":"2003","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lpm.2019.05.029_bib0390","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1756287216685027","article-title":"Nebivolol versus other beta blockers in patients with hypertension and erectile dysfunction","volume":"9","author":"Sharp","year":"2017","journal-title":"Ther Adv Urol"},{"key":"10.1016\/j.lpm.2019.05.029_bib0395","doi-asserted-by":"crossref","first-page":"S649","DOI":"10.1097\/00004872-198812040-00204","article-title":"Effects of first-line antihypertensive agents on sexual function and sex hormones","volume":"6","author":"Suzuki","year":"1988","journal-title":"J Hypertens Suppl"},{"key":"10.1016\/j.lpm.2019.05.029_bib0400","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1161\/CIRCULATIONAHA.109.864199","volume":"121","author":"B\u00f6hm","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2019.05.029_bib0405","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/00000441-200105000-00006","article-title":"Sexual dysfunction in hypertensive patients treated with losartan","volume":"321","author":"Llisterri","year":"2001","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.lpm.2019.05.029_bib0410","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000477388","article-title":"Losartan preserves erectile function by suppression of apoptosis and fibrosis of corpus cavernosum and corporal veno-occlusive dysfunction in diabetic rats","volume":"42","author":"Li","year":"2017","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.lpm.2019.05.029_bib0415","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/ijir.2012.4","article-title":"Losartan improves erectile dysfunction in diabetic patients: a clinical trial","volume":"24","author":"Chen","year":"2012","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.lpm.2019.05.029_bib0420","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.amjhyper.2005.03.733","article-title":"Quality of life and antihypertensive effect with nebivolol and losartan","volume":"18","author":"Van Bortel","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.lpm.2019.05.029_bib0425","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0895-7061(00)01214-0","article-title":"Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study","volume":"14","author":"Fogari","year":"2001","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.lpm.2019.05.029_bib0430","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/sj.jhh.1001490","article-title":"The safety of valsartan: results of a postmarketing surveillance study on 12881\u00a0patients in England","volume":"16","author":"Biswas","year":"2002","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.lpm.2019.05.029_bib0435","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/ijir.2008.28","article-title":"Effect of irbesartan on erectile function in patients with hypertension and metabolic syndrome","volume":"20","author":"Baumh\u00e4kel","year":"2008","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.lpm.2019.05.029_bib0440","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000350955","article-title":"The effect of combined antihypertensive treatment (felodipine with either irbesartan or metoprolol) on erectile function: a randomized controlled trial","volume":"125","author":"Yang","year":"2013","journal-title":"Cardiology"},{"key":"10.1016\/j.lpm.2019.05.029_bib0445","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00004872-199301000-00015","article-title":"Double-blind, parallel, comparative study on quality of life during treatment with amlodipine or enalapril in mild or moderate hypertensive patients: a multicentre study","volume":"11","author":"Omvik","year":"1993","journal-title":"J Hypertens"},{"key":"10.1016\/j.lpm.2019.05.029_bib0450","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1177\/106002809302701103","article-title":"Effect of frequently prescribed cardiovascular medications on sexual function: a pilot study","volume":"27","author":"Kroner","year":"1993","journal-title":"Ann Pharmacother"},{"issue":"Suppl 2","key":"10.1016\/j.lpm.2019.05.029_bib0455","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2165\/00003495-199000392-00013","article-title":"Comparative efficacy and safety of enalapril and sustained-release nifedipine in patients with mild to moderate hypertension. The Enalapril vs. Nifedipine French Study Group","volume":"39","author":"Gueret","year":"1990","journal-title":"Drugs"},{"key":"10.1016\/j.lpm.2019.05.029_bib0460","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/sj.ijir.3901041","article-title":"Antihypertensive treatment and erectile dysfunction in a cohort of type II diabetes patients","volume":"15","author":"Blumentals","year":"2003","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.lpm.2019.05.029_bib0465","first-page":"117","article-title":"The clinical evaluation of prazosin, a new antihypertensive agent","volume":"Spec No","author":"Pitts","year":"1975","journal-title":"Postgrad Med"},{"key":"10.1016\/j.lpm.2019.05.029_bib0470","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa030656","article-title":"The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia","volume":"349","author":"McConnell","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2019.05.029_bib0475","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.purol.2018.07.278","article-title":"Sexual consequences of BPH treatments","volume":"28","author":"Descazeaud","year":"2018","journal-title":"Prog Urol"},{"key":"10.1016\/j.lpm.2019.05.029_bib0480","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s11255-010-9847-z","article-title":"Effectiveness of doxazosin on erectile dysfunction in patients with lower urinary tract symptoms","volume":"43","author":"Faydaci","year":"2011","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.lpm.2019.05.029_bib0485","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/aja.2009.58","article-title":"The effect of alpha-blocker therapy on erectile functions in patients with lower urinary tract symptoms due to benign prostate hyperplasia","volume":"11","author":"Demir","year":"2009","journal-title":"Asian J Androl"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498219302817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498219302817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:06:16Z","timestamp":1760105176000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498219302817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0755498219302817"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2019.05.029","relation":{},"ISSN":["0755-4982"],"issn-type":[{"type":"print","value":"0755-4982"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dysfonction \u00e9rectile et traitement antihypertenseur\u00a0: impact des diff\u00e9rentes classes th\u00e9rapeutiques et conduite \u00e0 tenir \u00e0 l\u2019\u00e9gard du traitement","name":"articletitle","label":"Article Title"},{"value":"La Presse M\u00e9dicale","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lpm.2019.05.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}